Jon Hamilton Jon Hamilton is a correspondent for NPR's Science Desk.
Jon Hamilton 2010
Stories By

Jon Hamilton

Doby Photography/NPR
Jon Hamilton 2010
Doby Photography/NPR

Jon Hamilton

Correspondent, Science Desk

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.

In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans' social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors. During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Story Archive

Friday

Many people who take GLP-1 drugs like Wegovy and Zepbound for weight loss experience unpleasant side effects. Brain scientists are trying to find ways to avoid those side effects.
blackCAT/Getty Images/E+ hide caption

toggle caption
blackCAT/Getty Images/E+

Weight loss drugs and the brain

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5615168/nx-s1-9540419" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Weight loss drugs and the brain

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5611473/nx-s1-9540419" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Cognitive function tends to get worse as we age. But both mental and physical exercise can help fight that decline. Flavio Coelho/Getty Images hide caption

toggle caption
Flavio Coelho/Getty Images

Saturday

Leading neuroscientists say that ongoing disruptions in federal funding are causing many young scientists in the field to reconsider their career choice — with potentially dire consequences for research into Alzheimer's, autism and other brain disorders. Cemile Bingol/Digital Vision Vectors/Getty Images hide caption

toggle caption
Cemile Bingol/Digital Vision Vectors/Getty Images

Friday

Young brain researchers ponder other careers amid federal funding cuts

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5603615/nx-s1-9534480" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Scientists are taking a second look at a drug for Alzheimer's that may help patients who are particularly at risk of developing the disease. Jorg Greuel/Photodisc/Getty Images hide caption

toggle caption
Jorg Greuel/Photodisc/Getty Images

Alzheimer's drug

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5575561/nx-s1-9511753" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

A new study finds that cognitive training can increase the levels of a key chemical messenger in the brain responsible for decision-making, and reverse a process associated with aging. adventtr/iStockphoto/Getty Images hide caption

toggle caption
adventtr/iStockphoto/Getty Images

Intense mental exercise may be able to offset the effects of aging, research finds

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5581409/nx-s1-9496570" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

Intense mental exercise may be able to offset the effects of aging, research finds

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5573076/nx-s1-9496570" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Researchers are exploring the behavior of "death fold" proteins in the hopes of understanding why some cells die too soon and why others don't die soon enough. faithiecannoise/iStockphoto/Getty Images hide caption

toggle caption
faithiecannoise/iStockphoto/Getty Images

Thursday

Researchers may have discovered why cells sometimes kill themselves unnecessarily

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5536813/nx-s1-9486074" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Sunday

Monday

Immediately after Hurricane Katrina, thousands of survivors reported symptoms of PTSD. 20 years later, those same survivors are reporting increased resilience and recovery ... as well as some unexpected positive psychological growth. Jim Watson/Getty Images hide caption

toggle caption
Jim Watson/Getty Images

Why Do Some Hurricane Survivors Thrive After Disaster?

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5535581/nx-s1-mx-5736074" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

The Trump administration has suggested that leucovorin, a drug used in cancer treatment, might have some benefit for children with autism. Many researchers and families aren't so sure. Andrew Harnik/Getty Images hide caption

toggle caption
Andrew Harnik/Getty Images

Tuesday

Despite lack of evidence, Trump suggests link between acetaminophen use and autism

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5550256/nx-s1-9463391" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Autism linked to Tylenol New Corrected 2 Way Mix

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5550135/g-s1-90016" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

President Trump takes questions at the White House following an announcement that federal health officials are updating drug labeling to discourage the use of Tylenol during pregnancy. Andrew Harnik/Getty Images hide caption

toggle caption
Andrew Harnik/Getty Images

Lynn Milam says that a nerve-stimulating implant has dramatically improved her rheumatoid arthritis, allowing her and her husband, Donald, to regain the life they once enjoyed together. Lynn Milam hide caption

toggle caption
Lynn Milam

Rheumatoid arthritis stimulator

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5544463/nx-s1-9454661" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Rheumatoid arthritis stimulator

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5536838/nx-s1-9454661" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Illustration showing a healthy substantia nigra in a human brain. Degeneration of this structure is characteristic of Parkinson's disease. KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty Images hide caption

toggle caption
KATERYNA KON/SCIENCE PHOTO LIBRARY/Getty Images

What Do Stem Cells Mean For The Future Of Parkinson's?

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5519450/nx-s1-mx-5718068" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Postdoctoral researcher Erin Kunz holds up a microelectrode array that can be placed on the brain's surface as part of a brain-computer interface. Jim Gensheimer hide caption

toggle caption
Jim Gensheimer

Brain Implants Are Here – And Getting Better

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5527100/nx-s1-mx-5709336" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Saturday

Friday

A new study finds that a single dose of LSD can ease generalized anxiety disorder, or GAD, a disabling form of anxiety that affects about 1 in 10 people over the course of a year. mikkelwilliam/iStockphoto/Getty Images hide caption

toggle caption
mikkelwilliam/iStockphoto/Getty Images

Thursday

A single dose of LSD can treat anxiety and depression for months, study shows

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5525813/nx-s1-9439697" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday